March 2018  

AAOS 2018 Recap: C ompanies are responding differently to the challenge of creating products that correlate to better patient outcomes and quicker, less expensive procedures. We highlight the approaches of four OEMs from the exhibit hall floor: DePuy Synthes, Stryker, Okani Medical and United Orthopedic Corporation.
Our final estimates for 2017 orthopaedic industry revenue are being refined for the May 2018 publication of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORTĀ®. (Our preliminary estimation: the industry grew +3.7% in 2017 vs. 2016.) In announcing 2017 revenue, most companies included 2018 guidance and strategies to support growth in this year and beyond.

April issue

April issue


The purchase fills a portfolio gap, as Orthofix gains access to the M6-C and M6-L cervical and lumbar artificial discs to treat degenerative disease, currently CE Marked in the EU. The transaction is slated to close in 2Q18. FDA approval for M6-C could come by mid-2019.
SafeOp's technology provides information about the health and safety of nerves during retraction, and is designed to work without an additional professional in the O.R. for most procedures. Alphatec expects to introduce SafeOp services to the spine market in early 2019.
The pilot program will provide a Geisinger Health Plan member with lifetime coverage for future surgical care and costs following total hip replacement--including hospital care and device replacement for future revisions--while the patient remains with the Geisinger Health Plan and is treated by Geisinger providers.
Hospital for Special Surgery will help develop the system to address treatment of juvenile idiopathic arthritis patients or young patients with congenital dysplastic hip.

Is your UDI framework scalable? Now is the time to ask! Get answers to your pressing questions at OMTEC 2018 from UDI experts Karen Conway and Jay Crowley, who will speak on the global regulation and provide perspective for device manufacturers to implement a working system--including data management--that can scale with product development and compliance needs.